These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 11362207

  • 1. ABT-538 increases CD4 counts.
    Posit Aware; 1995; ():4. PubMed ID: 11362207
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M.
    Nature; 1995 Jan 12; 373(6510):123-6. PubMed ID: 7816094
    [Abstract] [Full Text] [Related]

  • 4. Update on HIV protease inhibitors.
    Vella S.
    AIDS Clin Care; 1995 Oct 12; 7(10):79-82, 88. PubMed ID: 11362832
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical potential of a new HIV protease inhibitor.
    Chapman S, Peterkin J, Quart B, Youle M.
    J Int Assoc Physicians AIDS Care; 1995 Jun 12; 1(5):24. PubMed ID: 11362604
    [Abstract] [Full Text] [Related]

  • 7. Indinavir--study highlights importance of CD4+ counts over viral load.
    TreatmentUpdate; 1998 Nov 12; 10(9):2-3. PubMed ID: 11365923
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protease inhibitors: implications for HIV research and treatment.
    Churchill SA.
    J Int Assoc Physicians AIDS Care; 1996 Jan 12; 2(1):13-8. PubMed ID: 11363325
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Agouron protease inhibitor.
    AIDS Treat News; 1995 Sep 29; (no 231):5. PubMed ID: 11362869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The next wave of protease inhibitors.
    Smart T.
    GMHC Treat Issues; 1995 Jun 29; 9(6):4. PubMed ID: 11362690
    [Abstract] [Full Text] [Related]

  • 16. Agouron protease inhibitor AG1343: activity reported.
    James JS.
    AIDS Treat News; 1995 May 05; (no 222):6. PubMed ID: 11362464
    [Abstract] [Full Text] [Related]

  • 17. The use of protease inhibitors. A sampling of opinions. Interview by Deborah J Cotton.
    Corey L, Hirsch M, Skowron G, Vella S.
    AIDS Clin Care; 1996 May 05; 8(5):37-41. PubMed ID: 11363605
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.
    Arranz Caso JA, López JC, Santos I, Estrada V, Castilla V, Sanz J, Sanz J, Molina JP, Fernández Guerrero M, Górgolas M.
    HIV Med; 2005 Sep 05; 6(5):353-9. PubMed ID: 16156884
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire.
    Borget MY, Diallo K, Adje-Toure C, Chorba T, Nkengasong JN.
    J Clin Virol; 2009 May 05; 45(1):72-5. PubMed ID: 19375979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.